Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Larimar Therapeutics
Company

Larimar Therapeutics

Tracked across 1 events · 7 articles · First seen Feb 25, 2026 · Last active Feb 26, 2026

Sentiment
20
Attention
2
Events
1
Relationships
3
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
2 20
Business
Larimar Therapeutics Upsized $100M Public Offering
Larimar Therapeutics announced the pricing of an upsized underwritten public offering of 20 million shares of its common stock at $5.00 per share, expecting to receive gross proceeds of $100 million. This offering will support the development of nomlabofusp and for working capital and general corporate purposes.
Feb 25, 2026 · 7 articles
Relationships (3)
Citizens Financial Group===Citizens Capital Markets lead manager ↔ Larimar Therapeutics Citizens Financial Group===Citizens Capital Markets is the lead manager for Lari
JPMorgan Chase===J. P. Morgan joint bookrunning manager ↔ Larimar Therapeutics JPMorgan Chase===J. P. Morgan is a joint bookrunning manager for Larimar Therape
Jones Company co-manager ↔ Larimar Therapeutics Jones Company is a co-manager for Larimar Therapeutics' public offering.
NEWSDESK
Track Larimar Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.